Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial

A. Molto*, C. Lopez-Medina, F.E. Van den Bosch, A. Boonen, C. Webers, E. Dernis, F.A. van Gaalen, M. Soubrier, P. Claudepierre, A. Baillet, M. Starmans-Kool, A. Spoorenberg, P. Jacques, P. Carron, R. Joos, J. Lenaerts, L. Gossec, S. Pouplin, A. Ruyssen-Witrand, L. SparsaA. van Tubergen, D. van der Heijde, M. Dougados

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1436-1444
Number of pages9
JournalAnnals of the Rheumatic Diseases
Volume80
Issue number11
DOIs
Publication statusPublished - 1 Nov 2021

Keywords

  • spondylitis
  • ankylosing
  • therapeutics
  • outcome and process assessment
  • healthcare
  • DISEASE-ACTIVITY SCORE
  • ANKYLOSING-SPONDYLITIS
  • PSORIATIC-ARTHRITIS
  • RHEUMATOID-ARTHRITIS
  • ADALIMUMAB
  • ASAS
  • RECOMMENDATIONS
  • IMPROVEMENT
  • CRITERIA
  • ABILITY

Cite this